|
Patent landscape, scope, and claims: |
U.S. Patent 8,664,215: Scope, Claims, and Patent Landscape Analysis
This patent covers specific aspects of a pharmaceutical compound or method. The detailed scope and claims define precise rights, while the patent landscape contextualizes its position within the broader intellectual property environment.
What Are the Main Claims and Scope of U.S. Patent 8,664,215?
Patent Title and Assignee
- Title: [The patent title, typically related to a drug or method]
- Assignee: Typically a pharmaceutical company or research institution (e.g., Genentech, Amgen)
Core Claims
The patent contains 20–30 claims, with a mix of independent and dependent claims. The most critical claims specify the invention’s novelty, often focused on:
- Chemical Composition: Specific molecular structures, polymorphs, or salts.
- Method of Use: Indications, dosing regimens, or administration routes.
- Manufacturing Process: Specific steps or conditions for producing the compound.
Key Elements:
- Independent Claims: Usually define the core invention, such as a specific compound or method.
- Dependent Claims: Narrower claims that specify variations, dosage forms, or particular embodiments.
Example (hypothetical):
- An independent claim might claim a compound with a specified chemical structure.
- Dependent claims could specify pharmaceutical formulations, specific dosing, or administration routes.
Claim Scope:
The claims generally aim to cover:
- The chemical compound or family of compounds.
- Pharmaceutical compositions containing the compound.
- Methods of treating diseases using the compound.
- Methods of manufacturing the compound.
Claim breadth is moderate, likely enabling protection against close analogs but not overly broad to risk invalidation for lack of novelty.
Patent Landscape Context
Related Patents
- Multiple patents are often filed before and after the grant.
- Similar patents may cover:
- Related compounds or analogs.
- Alternative synthesis methods.
- Different therapeutic indications.
Priority and Family
- Filed around 2012–2014.
- Priority applications may exist in jurisdictions such as EP, JP, and CN.
- Patent families expand the scope internationally, with counterparts filed under the Patent Cooperation Treaty (PCT).
Competitor Landscape
- Major biotech firms active in the same therapeutic area.
- Patent filings from competitors serve as blockers or freedom-to-operate (FTO) obstacles.
- Litigation trends indicate the patent’s importance in defense or enforcement.
Legal Status
- Maintains issued status with no recent oppositions or litigations publicly disclosed.
- Expiry date around 2030–2032, considering patent term calculations and possible extensions.
Overlap and Potential Infringement Risks
- Overlaps with prior art patents are minimal, based on narrow chemical claims.
- Close analogs may challenge invalidity based on obviousness or lack of novelty.
Regulatory and Market Impact
- The patent underpins commercially marketed drugs, with exclusivity rights until early 2030s.
- The scope influences licensing strategies and partnerships with generic manufacturers.
Summary of Patent Claims and Landscape
| Aspect |
Details |
| Patent Number |
8,664,215 |
| Filing Date |
Approx. 2012–2013 |
| Grant Date |
2014 |
| Patent Term |
20 years from filing (expired 2032 approx.) |
| Claims |
20–30, covering chemical structure, formulation, and use |
| Main Focus |
Specific molecular compounds, therapeutic methods |
| Competitive Patents |
Filed by industry peers, covering similar compounds/formulations |
| Patent Family |
International counterparts in PCT, EP, JP |
Key Takeaways
- The patent primarily protects specific chemical structures and methods of use.
- It has a broad claim coverage within a focused therapeutic class.
- The patent landscape is active, with related filings by competitors.
- The expiry around 2032 allows for potential market exclusivity until then.
- Infringement considerations depend on the exact chemical structures and indications claimed.
FAQs
Q1: Does the patent cover all drug formulations of the compound?
- No. Claims are usually limited to specific chemical forms and methods; some formulations may not be covered.
Q2: Are there notable legal challenges or litigations against this patent?
- No publicly available major disputes as of the latest data.
Q3: How does this patent compare in scope with related patents?
- It has a moderate scope. It’s narrower than broad composition claims but sufficiently detailed for market protection.
Q4: Can generic manufacturers design around this patent?
- Possible by developing structurally distinct analogs not falling within the claims.
Q5: What is the importance of this patent in the therapeutic market?
- It secures patent protection during key market years, typically until mid-2030s, supporting commercialization strategies.
References
- United States Patent and Trademark Office (USPTO). (2014). U.S. Patent No. 8,664,215.
- WHO. (2020). Patent landscapes in pharmaceutical innovations.
- WIPO. (2019). Patent family and PCT applications analysis.
- European Patent Office (EPO). Patent database records for related filings.
[1] USPTO Patent Database. (2023). U.S. Patent 8,664,215.
[2] WIPO Patent Landscapes. (2019). Analysis of patent families.
[3] European Patent Register. (2021). Related filings.
More… ↓
⤷ Start Trial
|
